St. Jude wins FDA nod for next-gen defibrillators

06/12/2013 | RTT News

St. Jude Medical's Ellipse and SJM Assura line of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators has been approved by the FDA. The next-generation devices come with a low-friction coating to help cut the risk for lead abrasion and feature technology designed to allow high-voltage treatment delivery.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC